resident's general practitioner, who might or might not be the visiting medical officer.
A study in Leicestershire of levels of dependency in residents4 showed that 25% were in need of nursing care. The residential homes have, indeed, repeated one of the lessons of history and recreated the poor-law infirmaries. All the ingredients have reappeared: lack of assessment on admission, lack of defined medical responsibility, inadequate notes, failure to provide for rehabilitation, lack of diagnostic facilities, and an untrained staff.
When it talks of commissioning research into a "new concept" of nursing homes in the hospital sector, the Government seems unaware that it has already created a whole stock of inadequate local authority nursing homes, full of people requiring nursing care. The major reason that elderly people cannot cope at home is because they are ill. Unless medical responsibility for the care of the elderly in residential homes is properly defined and nursing and rehabilitation staff are provided, the policy of increasing turnover in this sector is doomed to failure. The policy is based on straw in its assumption that the elderly are in need of care because they are old and not because they are ill. Diseases such as osteomalacia lead to inability to cope at home; meals on wheels, a home help, and holiday admissions are not, and never will be, the correct treatment.
However good the home care services, some elderly people will have to be cared for in institutions. Some Some years ago in the United States up to 140 000 deaths were said to occur each year from adverse reactions to drugs,3 4 and one-seventh of all hospital days were said to be devoted to the care of patients suffering from drug toxicity.5 These statements are now seen as exaggerations, but considerable alarm was caused at the time. The trouble was caused partly by lack of definition of an adverse drug reaction. Clear definitions are now accepted which categorise drug reactions as definite, probable, possible, conditional, and doubtful.3 Medical journals have helped to minimise unnecessary anxiety by printing reports in only the first two or, at most, three categories.
Using these criteria, comprehensive studies (such as those carried out by the Boston Collaborative Drug Surveillance Program) have shown that among patients admitted to an acute medical ward adverse drug reactions will be seen in 10% to 15% of patients6 7 but that most will be mild and, at worst, only an inconvenience to the patient. Life-threatening reactions among such patients have been reported to occur in 3% of patients in American hospitals,4 but in a combined British and American study Lawson and his colleagues8 found only 28 instances of life-threatening reactions among 2580 medical inpatients (1@10%). These reactions were more common in patients with known cancer, and hyperkalaemia and hypokalaemia were the most common drug-induced reactions. In a further study9 Lawson and his colleagues found 73 cases of severe hypokalaemia over a three-year period, with a particularly high incidence in patients with myeloid leukaemia. In nearly 27 000 carefully monitored patients fewer than one in 1000 were considered to have died as the result of an adverse drug reaction.'0 Digoxin and cytotoxic agents figured prominently in this series, and six of the 24 deaths might have been preventable.
What about the admission to hospital of patients primarily because of an adverse drug reaction ? In four recent studies1'-'4 the results were consistent, with 2-9%, 3'7%, 4d1%, and 5.7%0 of admissions respectively being primarily due to an adverse drug reaction. Admissions to intensive care units might be thought to be a measure of more severe drug reactions, but the data can be misinterpreted. In a study in France 1-8% of admissions over a 10-year period were due to drug toxicity.15 In another French study Trunet and his colleagues'6 found that 40 out of 325 admissions to an intensive care unit were due to iatrogenic disease, but this high proportion was probably due to the admission of most patients from surrounding hospitals rather than from the patient's home. Adverse drug reactions are not solely the province of hospital doctors,'7 and one in 40 of consultations in general practice is due to iatrogenic disease. 18 Certain groups of patients are at higher-than-average risk of developing an adverse drug reaction. These reactions are more common in women than in men," 14 particularly white women rather than black women," and there is increasing interest in the genetic contribution to adverse drug reactions.'9 Adverse reactions are more likely in the elderly and in patients given multiple drug treatment.'3 14 The disease itself will also contribute to the likelihood of an adverse drug reaction, drug reactions being more likely in patients with impaired renal function'3 14 and with cancer.9 16 In most reports certain drugs stand out and we should be particularly careful in their use: these include aspirin, digoxin, diuretics, antibiotics, anticoagulants, and corticosteroids and other immunosuppressive drugs.
In general, severe adverse reactions are uncommon, and the benefits of drug treatment usually outweigh the disadvantages.
Nevertheless, nmost studies show that 25% of these adverse drug reactions are preventable.'0 13 14 What can we as prescribing doctors do to prevent these reactions ? Firstly, we must all have a higher index of suspicion. This does not mean rushing into print at the slightest provocation, but thinking that an unusual or unexpected event may be due to drug toxicity. If in doubt, a yellow adverse drug reaction card should be filled in and posted to the Committee on Safety of Medicines. Secondly, we should take particular care in our use of highrisk drugs and in high-risk patients. Finally, local schemes for monitoring adverse drug reactions both in hospitals and in general practice will keep the possibility at the front of our minds. Such a scheme was mooted in these columns two years
